Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Lisa Maier to Adult

This is a "connection" page, showing publications Lisa Maier has written about Adult.

 
Connection Strength
 
 
 
0.649
 
  1. Liao SY, Petrache I, Fingerlin TE, Maier LA. Association of inhaled and systemic corticosteroid use with Coronavirus Disease 2019 (COVID-19) test positivity in patients with chronic pulmonary diseases. Respir Med. 2021 01; 176:106275.
    View in: PubMed
    Score: 0.045
  2. Bhargava M, Viken KJ, Barkes B, Griffin TJ, Gillespie M, Jagtap PD, Sajulga R, Peterson EJ, Dincer HE, Li L, Restrepo CI, O'Connor BP, Fingerlin TE, Perlman DM, Maier LA. Novel protein pathways in development and progression of pulmonary sarcoidosis. Sci Rep. 2020 08 06; 10(1):13282.
    View in: PubMed
    Score: 0.044
  3. Li L, Silveira LJ, Hamzeh N, Gillespie M, Mroz PM, Mayer AS, Fingerlin TE, Maier LA. Beryllium-induced lung disease exhibits expression profiles similar to sarcoidosis. Eur Respir J. 2016 06; 47(6):1797-808.
    View in: PubMed
    Score: 0.033
  4. Liu H, Patel D, Welch AM, Wilson C, Mroz MM, Li L, Rose CS, Van Dyke M, Swigris JJ, Hamzeh N, Maier LA. Association Between Occupational Exposures and Sarcoidosis: An Analysis From Death Certificates in the United States, 1988-1999. Chest. 2016 08; 150(2):289-98.
    View in: PubMed
    Score: 0.032
  5. Hamzeh N, Voelker A, Forssén A, Gottschall EB, Rose C, Mroz P, Maier LA. Efficacy of mycophenolate mofetil in sarcoidosis. Respir Med. 2014 Nov; 108(11):1663-9.
    View in: PubMed
    Score: 0.029
  6. Fireman E, Lerman Y, Stark M, Pardo A, Schwarz Y, Van Dyke MV, Elliot J, Barkes B, Newman L, Maier L. A novel alternative to environmental monitoring to detect workers at risk for beryllium exposure-related health effects. J Occup Environ Hyg. 2014; 11(12):809-18.
    View in: PubMed
    Score: 0.028
  7. Van Dyke MV, Martyny JW, Mroz MM, Silveira LJ, Strand M, Cragle DL, Tankersley WG, Wells SM, Newman LS, Maier LA. Exposure and genetics increase risk of beryllium sensitisation and chronic beryllium disease in the nuclear weapons industry. Occup Environ Med. 2011 Nov; 68(11):842-8.
    View in: PubMed
    Score: 0.023
  8. Van Dyke MV, Martyny JW, Mroz MM, Silveira LJ, Strand M, Fingerlin TE, Sato H, Newman LS, Maier LA. Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers. Am J Respir Crit Care Med. 2011 Jun 15; 183(12):1680-8.
    View in: PubMed
    Score: 0.023
  9. Pacheco KA, Rose CS, Silveira LJ, Van Dyke MV, Goelz K, MacPhail K, Maier LA. Gene-environment interactions influence airways function in laboratory animal workers. J Allergy Clin Immunol. 2010 Aug; 126(2):232-40.
    View in: PubMed
    Score: 0.022
  10. Sato H, Silveira L, Fingerlin T, Dockstader K, Gillespie M, Lagan AL, Lympany P, Sawyer RT, du Bois RM, Welsh KI, Maier LA. TNF polymorphism and bronchoalveolar lavage cell TNF-alpha levels in chronic beryllium disease and beryllium sensitization. J Allergy Clin Immunol. 2007 Mar; 119(3):687-96.
    View in: PubMed
    Score: 0.017
  11. Wasfi YS, Rose CS, Murphy JR, Silveira LJ, Grutters JC, Inoue Y, Judson MA, Maier LA. A new tool to assess sarcoidosis severity. Chest. 2006 May; 129(5):1234-45.
    View in: PubMed
    Score: 0.016
  12. Newman LS, Mroz MM, Balkissoon R, Maier LA. Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk. Am J Respir Crit Care Med. 2005 Jan 01; 171(1):54-60.
    View in: PubMed
    Score: 0.015
  13. Maier LA, McGrath DS, Sato H, Lympany P, Welsh K, Du Bois R, Silveira L, Fontenot AP, Sawyer RT, Wilcox E, Newman LS. Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease. J Immunol. 2003 Dec 15; 171(12):6910-8.
    View in: PubMed
    Score: 0.014
  14. Maier LA, Kittle LA, Mroz MM, Newman LS. Beryllium-stimulated neopterin as a diagnostic adjunct in chronic beryllium disease. Am J Ind Med. 2003 Jun; 43(6):592-601.
    View in: PubMed
    Score: 0.013
  15. Maier LA. Clinical approach to chronic beryllium disease and other nonpneumoconiotic interstitial lung diseases. J Thorac Imaging. 2002 Oct; 17(4):273-84.
    View in: PubMed
    Score: 0.013
  16. Greaves SA, Ravindran A, Santos RG, Chen L, Falta MT, Wang Y, Mitchell AM, Atif SM, Mack DG, Tinega AN, Maier LA, Dai S, Pinilla C, Grunewald J, Fontenot AP. CD4+ T cells in the lungs of acute sarcoidosis patients recognize an Aspergillus nidulans epitope. J Exp Med. 2021 10 04; 218(10).
    View in: PubMed
    Score: 0.012
  17. Lin NW, Maier LA, Mroz MM, Jacobson S, MacPhail K, Liu S, Lei Z, Barkes BQ, Fingerlin TE, Hamzeh N, Mayer AS, Restrepo CI, Chhabra D, Yang IV, Li L. Genomic biomarkers in chronic beryllium disease and sarcoidosis. Respir Med. 2021 10; 187:106390.
    View in: PubMed
    Score: 0.012
  18. Maier LA, Sawyer RT, Tinkle SS, Kittle LA, Barker EA, Balkissoon R, Rose C, Newman LS. IL-4 fails to regulate in vitro beryllium-induced cytokines in berylliosis. Eur Respir J. 2001 Mar; 17(3):403-15.
    View in: PubMed
    Score: 0.011
  19. Crouser ED, Julian MW, Bicer S, Ghai V, Kim TK, Maier LA, Gillespie M, Hamzeh NY, Wang K. Circulating exosomal microRNA expression patterns distinguish cardiac sarcoidosis from myocardial ischemia. PLoS One. 2021; 16(1):e0246083.
    View in: PubMed
    Score: 0.011
  20. Phalke S, Aviszus K, Rubtsova K, Rubtsov A, Barkes B, Powers L, Warner B, Crooks JL, Kappler JW, Fernández-Pérez ER, Maier LA, Hamzeh N, Marrack P. Age-associated B Cells Appear in Patients with Granulomatous Lung Diseases. Am J Respir Crit Care Med. 2020 10 01; 202(7):1013-1023.
    View in: PubMed
    Score: 0.011
  21. Raghu G, Remy-Jardin M, Ryerson CJ, Myers JL, Kreuter M, Vasakova M, Bargagli E, Chung JH, Collins BF, Bendstrup E, Chami HA, Chua AT, Corte TJ, Dalphin JC, Danoff SK, Diaz-Mendoza J, Duggal A, Egashira R, Ewing T, Gulati M, Inoue Y, Jenkins AR, Johannson KA, Johkoh T, Tamae-Kakazu M, Kitaichi M, Knight SL, Koschel D, Lederer DJ, Mageto Y, Maier LA, Matiz C, Morell F, Nicholson AG, Patolia S, Pereira CA, Renzoni EA, Salisbury ML, Selman M, Walsh SLF, Wuyts WA, Wilson KC. Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2020 08 01; 202(3):e36-e69.
    View in: PubMed
    Score: 0.011
  22. Burian E, Sollmann N, Ritschl LM, Palla B, Maier L, Zimmer C, Probst F, Fichter A, Miloro M, Probst M. High resolution MRI for quantitative assessment of inferior alveolar nerve impairment in course of mandible fractures: an imaging feasibility study. Sci Rep. 2020 07 14; 10(1):11566.
    View in: PubMed
    Score: 0.011
  23. Harper LJ, Gerke AK, Wang XF, Ribeiro Neto ML, Baughman RP, Beyer K, Drent M, Judson MA, Maier LA, Serchuck L, Singh N, Culver DA. Income and Other Contributors to Poor Outcomes in U.S. Patients with Sarcoidosis. Am J Respir Crit Care Med. 2020 04 15; 201(8):955-964.
    View in: PubMed
    Score: 0.011
  24. Ryan SM, Vestal B, Maier LA, Carlson NE, Muschelli J. Template Creation for High-Resolution Computed Tomography Scans of the Lung in R Software. Acad Radiol. 2020 08; 27(8):e204-e215.
    View in: PubMed
    Score: 0.011
  25. Ryan SM, Fingerlin TE, Mroz M, Barkes B, Hamzeh N, Maier LA, Carlson NE. Radiomic measures from chest high-resolution computed tomography associated with lung function in sarcoidosis. Eur Respir J. 2019 08; 54(2).
    View in: PubMed
    Score: 0.010
  26. Maier LA, Raynolds MV, Young DA, Barker EA, Newman LS. Angiotensin-1 converting enzyme polymorphisms in chronic beryllium disease. Am J Respir Crit Care Med. 1999 Apr; 159(4 Pt 1):1342-50.
    View in: PubMed
    Score: 0.010
  27. Liu B, Maier LA, Hamzeh N, MacPhail K, Mroz MM, Liu H, Li L. Polymorphism of FCGR3A gene in chronic beryllium disease. Genes Immun. 2019 07; 20(6):493-499.
    View in: PubMed
    Score: 0.010
  28. Silveira LJ, Strand M, Van Dyke MV, Mroz MM, Faino AV, Dabelea DM, Maier LA, Fingerlin TE. Clinical tool for disease phenotyping in granulomatous lung disease. PLoS One. 2017; 12(11):e0188119.
    View in: PubMed
    Score: 0.009
  29. Hena KM, Yip J, Jaber N, Goldfarb D, Fullam K, Cleven K, Moir W, Zeig-Owens R, Webber MP, Spevack DM, Judson MA, Maier L, Krumerman A, Aizer A, Spivack SD, Berman J, Aldrich TK, Prezant DJ. Clinical Course of Sarcoidosis in World Trade Center-Exposed Firefighters. Chest. 2018 01; 153(1):114-123.
    View in: PubMed
    Score: 0.009
  30. Hamzeh N, Li L, Barkes B, Huang J, Canono B, Gillespie M, Maier L, Day B. The effect of an oral anti-oxidant, N-Acetyl-cysteine, on inflammatory and oxidative markers in pulmonary sarcoidosis. Respir Med. 2016 Mar; 112:106-11.
    View in: PubMed
    Score: 0.008
  31. Moller DR, Koth LL, Maier LA, Morris A, Drake W, Rossman M, Leader JK, Collman RG, Hamzeh N, Sweiss NJ, Zhang Y, O'Neal S, Senior RM, Becich M, Hochheiser HS, Kaminski N, Wisniewski SR, Gibson KF. Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) Study. Sarcoidosis Protocol. Ann Am Thorac Soc. 2015 Oct; 12(10):1561-71.
    View in: PubMed
    Score: 0.008
  32. Stark M, Lerman Y, Kapel A, Pardo A, Schwarz Y, Newman L, Maier L, Fireman E. Biological exposure metrics of beryllium-exposed dental technicians. Arch Environ Occup Health. 2014; 69(2):89-99.
    View in: PubMed
    Score: 0.007
  33. Pacheco K, Barker L, Maier L, Erb S, Sills M, Knight V. Development of a validated blood test for nickel sensitization. J Allergy Clin Immunol. 2013 Sep; 132(3):767-769.
    View in: PubMed
    Score: 0.007
  34. Freeman AM, Curran-Everett D, Weinberger HD, Fenster BE, Buckner JK, Gottschall EB, Sauer WH, Maier LA, Hamzeh NY. Predictors of cardiac sarcoidosis using commonly available cardiac studies. Am J Cardiol. 2013 Jul 15; 112(2):280-5.
    View in: PubMed
    Score: 0.007
  35. Fireman E, Shai AB, Lerman Y, Topilsky M, Blanc PD, Maier L, Li L, Chandra S, Abraham JM, Fomin I, Aviram G, Abraham JL. Chest wall shrapnel-induced beryllium-sensitization and associated pulmonary disease. Sarcoidosis Vasc Diffuse Lung Dis. 2012 Oct; 29(2):147-50.
    View in: PubMed
    Score: 0.006
  36. Wang F, Smith N, Maier L, Xia W, Hammerberg C, Chubb H, Chen C, Riblett M, Johnston A, Gudjonsson JE, Helfrich Y, Kang S, Fisher GJ, Voorhees JJ. Etanercept suppresses regenerative hyperplasia in psoriasis by acutely downregulating epidermal expression of interleukin (IL)-19, IL-20 and IL-24. Br J Dermatol. 2012 Jul; 167(1):92-102.
    View in: PubMed
    Score: 0.006
  37. Martin AK, Mack DG, Falta MT, Mroz MM, Newman LS, Maier LA, Fontenot AP. Beryllium-specific CD4+ T cells in blood as a biomarker of disease progression. J Allergy Clin Immunol. 2011 Nov; 128(5):1100-6.e1-5.
    View in: PubMed
    Score: 0.006
  38. Ribeiro M, Fritscher LG, Al-Musaed AM, Balter MS, Hoffstein V, Mazer BD, Maier LA, Liss GM, Tarlo SM. Search for chronic beryllium disease among sarcoidosis patients in Ontario, Canada. Lung. 2011 Jun; 189(3):233-41.
    View in: PubMed
    Score: 0.006
  39. Mack DG, Lanham AM, Falta MT, Palmer BE, Maier LA, Fontenot AP. Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects. Am J Respir Crit Care Med. 2010 Jun 01; 181(11):1241-9.
    View in: PubMed
    Score: 0.005
  40. Dobis DR, Sawyer RT, Gillespie MM, Newman LS, Maier LA, Day BJ. Sulfasalazine and mesalamine modulate beryllium-specific lymphocyte proliferation and inflammatory cytokine production. Am J Respir Cell Mol Biol. 2010 Oct; 43(4):458-64.
    View in: PubMed
    Score: 0.005
  41. Mroz MM, Maier LA, Strand M, Silviera L, Newman LS. Beryllium lymphocyte proliferation test surveillance identifies clinically significant beryllium disease. Am J Ind Med. 2009 Oct; 52(10):762-73.
    View in: PubMed
    Score: 0.005
  42. Mack DG, Lanham AM, Palmer BE, Maier LA, Fontenot AP. CD27 expression on CD4+ T cells differentiates effector from regulatory T cell subsets in the lung. J Immunol. 2009 Jun 01; 182(11):7317-24.
    View in: PubMed
    Score: 0.005
  43. Pacheco K, Maier L, Silveira L, Goelz K, Noteware K, Luna B, du Bois R, Murphy J, Rose C. Association of Toll-like receptor 4 alleles with symptoms and sensitization to laboratory animals. J Allergy Clin Immunol. 2008 Nov; 122(5):896-902.e4.
    View in: PubMed
    Score: 0.005
  44. Wasfi YS, Silveira LJ, Jonth A, Hokanson JE, Fingerlin T, Sato H, Parsons CE, Lympany P, Welsh K, du Bois RM, Newman LS, Maier LA. Fas promoter polymorphisms: genetic predisposition to sarcoidosis in African-Americans. Tissue Antigens. 2008 Jul; 72(1):39-48.
    View in: PubMed
    Score: 0.005
  45. Palmer BE, Mack DG, Martin AK, Gillespie M, Mroz MM, Maier LA, Fontenot AP. Up-regulation of programmed death-1 expression on beryllium-specific CD4+ T cells in chronic beryllium disease. J Immunol. 2008 Feb 15; 180(4):2704-12.
    View in: PubMed
    Score: 0.005
  46. Dobis DR, Sawyer RT, Gillespie MM, Huang J, Newman LS, Maier LA, Day BJ. Modulation of lymphocyte proliferation by antioxidants in chronic beryllium disease. Am J Respir Crit Care Med. 2008 May 01; 177(9):1002-11.
    View in: PubMed
    Score: 0.005
  47. Jonth AC, Silveira L, Fingerlin TE, Sato H, Luby JC, Welsh KI, Rose CS, Newman LS, du Bois RM, Maier LA. TGF-beta 1 variants in chronic beryllium disease and sarcoidosis. J Immunol. 2007 Sep 15; 179(6):4255-62.
    View in: PubMed
    Score: 0.005
  48. Sawyer RT, Fontenot AP, Barnes TA, Parsons CE, Tooker BC, Maier LA, Gillespie MM, Gottschall EB, Silveira L, Hagman J, Newman LS. Beryllium-induced TNF-alpha production is transcription-dependent in chronic beryllium disease. Am J Respir Cell Mol Biol. 2007 Feb; 36(2):191-200.
    View in: PubMed
    Score: 0.004
  49. Pott GB, Palmer BE, Sullivan AK, Silviera L, Maier LA, Newman LS, Kotzin BL, Fontenot AP. Frequency of beryllium-specific, TH1-type cytokine-expressing CD4+ T cells in patients with beryllium-induced disease. J Allergy Clin Immunol. 2005 May; 115(5):1036-42.
    View in: PubMed
    Score: 0.004
  50. Sackett HM, Maier LA, Silveira LJ, Mroz MM, Ogden LG, Murphy JR, Newman LS. Beryllium medical surveillance at a former nuclear weapons facility during cleanup operations. J Occup Environ Med. 2004 Sep; 46(9):953-61.
    View in: PubMed
    Score: 0.004
  51. Sawyer RT, Day BJ, Fadok VA, Chiarappa-Zucca M, Maier LA, Fontenot AP, Silveira L, Newman LS. Beryllium-ferritin: lymphocyte proliferation and macrophage apoptosis in chronic beryllium disease. Am J Respir Cell Mol Biol. 2004 Oct; 31(4):470-7.
    View in: PubMed
    Score: 0.004
  52. Lundgren RA, Maier LA, Rose CS, Balkissoon RC, Newman LS. Indirect and direct gas exchange at maximum exercise in beryllium sensitization and disease. Chest. 2001 Nov; 120(5):1702-8.
    View in: PubMed
    Score: 0.003
  53. Deubner D, Kelsh M, Shum M, Maier L, Kent M, Lau E. Beryllium sensitization, chronic beryllium disease, and exposures at a beryllium mining and extraction facility. Appl Occup Environ Hyg. 2001 May; 16(5):579-92.
    View in: PubMed
    Score: 0.003
  54. Newman LS, Mroz MM, Maier LA, Daniloff EM, Balkissoon R. Efficacy of serial medical surveillance for chronic beryllium disease in a beryllium machining plant. J Occup Environ Med. 2001 Mar; 43(3):231-7.
    View in: PubMed
    Score: 0.003
  55. Kelleher PC, Martyny JW, Mroz MM, Maier LA, Ruttenber AJ, Young DA, Newman LS. Beryllium particulate exposure and disease relations in a beryllium machining plant. J Occup Environ Med. 2001 Mar; 43(3):238-49.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)